Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.
Optimeos Life Sciences's investors include National Science Foundation, NJEDA, Hatch Biofund Management.
Optimeos Life Sciences is headquartered in Princeton, United States.
Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.
Optimeos Life Sciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optimeos Life Sciences — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/optimeos-life-sciences. Accessed August 14, 2026.
VCBacked. (2026). Optimeos Life Sciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/optimeos-life-sciences
{{cite web |title=Optimeos Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/optimeos-life-sciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated